DR.GOEL LIFE DIAGNOSTIC PVT. LTD.

NAME :Mrs. VIMLA GUPTA TEST REQUEST ID :012204200035

AGE/SEX :60 YRS/FEMALE REG DATE/TIME :20/Apr/2022 09:13AM
COLLECTED AT :LIFE SAMPLE COLLECTION DATE :20/Apr/2022 09:35AM
REFERRED BY :Dr. POONAM GUPTA, MD REPORTED DATE :20/Apr/2022 11:07AM

Test Name Result Ref. Range Unit

HAEMATOLOGY
HB, TLC, DLC
Haemoglobin (Hb) 11.5 13.0-17.0 g/dl
Cell counter
Total Leucocyte Count(TLC) 7800 4000-10000 /cumm
Beckman coulter-5 part diff. analyzer
Differential Leucocyte Count
Neutrophil 65 40.0-70.0 %
VCS/Microscopy
Lymphocyte 30 20-40 %
Eosinophils 2 1.0-6.0 %
VCS/Microscopy
Monocytes 3 02.0-10.0 %
VCS/Microscopy
Basophils 0 00.0-02.0 %
VCS/Microscopy
BIOCHEMISTRY
Blood Glucose Random 181.3 70.0-140.0 mg/dL
G-POD.AU480, Beckman Coulter
LIVER FUNCTION TEST (LFT), Serum
Bilirubin, Total 0.98 0.20-1.30 mg/dl
AU480, Beckman Coulter
Bilirubin, Direct 0.32 0.0-0.40 mg/dl
AU480, Beckman Coulter
Bilirubin, Indirect 0.66 0.10-1.10 mg/dl
Calculated
SGOT (AST), Serum 19.7 5.0-35.0 IU/L
AU480, Beckman Coulter
SGPT (ALT), Serum 23.2 5.0-35.0 IU/L
AU480, Beckman Coulter
Alkaline Phosphatase (ALP), Serum 74.3 38.0-126.0 IU/L
AU480, Beckman Coulter
Protein, Total 7.65 6.00 - 8.00 g/dl
Gel Electrophoresis
Albumin, Serum 4.51 3.2-5.0 g/dL
AU480, Beckman Coulter
Globulin 3.14 2.00-3.50 gm/dl
Calculated

Print DateTime: 20/04/2022 12:09 PM Printed By:Mohd Israr Ahmed Page 1 of 3

 NAME :Mrs. VIMLA GUPTA TEST REQUEST ID :012204200035
AGE/SEX :60 YRS/FEMALE REG DATE/TIME :20/Apr/2022 09:13AM
COLLECTED AT :LIFE SAMPLE COLLECTION DATE :20/Apr/2022 09:35AM
REFERRED BY :Dr. POONAM GUPTA, MD REPORTED DATE :20/Apr/2022 11:07AM

Test Name Result Ref. Range Unit

A/G Ratio 1.44 1.10 - 2.50

Calculated
LIPID PROFILE, Serum
Total Cholesterol 175.0 Desirable <200.0 mg/dL
AU480, Beckman Coulter Borderline 200.0-239.9
High Risk >=240.0
Triglyceride 123.9 Normal <150.0 mg/dL
AU480, Beckman Coulter Borderline 150.0-199.9
High 200.0-499.9
Very High >500.0
HDL Cholesterol 35.8 Major risk factor for heart mg/dL
True HDL-Direct Homogenous Method disease <40.0
Negative risk factor for heart
disease =>60.0
LDL Cholesterol 114 Recommended <130.0 mg/dL
TRUE LDL-Direct Homogenuos Method Moderate Risk 130.0-159.9
High Risk >160.0
VLDL Cholesterol 24.8 0.0-30.0 mg/dL
Calculated
Total / HDL Cholesterol Ratio 4.9 Low Risk 3.3-4.4
Calculated Average Risk 4.4-7.1
Moderate Risk 7.1-11.0
High Risk >11.0
LDL / HDL Cholestrol Ratio 3.20 0.0 - 3.5
Calculated
Kidney Function Test I (KFT I), Serum
Urea, Blood 21.30 13.0-43.0 mg/dl
AU480, Beckman Coulter
Creatinine, Serum 0.83 0.50-1.04 mg/dl
Enzymatic Creatinine- AU480, Beckman Coulter
Uric Acid, Serum 4.57 2.5-6.0 mg/dl
AU480, Beckman Coulter
Sodium, Serum 138.2 136.0 - 146.0 mmol/L
Ion Selective Electrode
Potassium, Serum 4.50 3.50 - 5.10 mmol/L
Ion Selective Electrode
Chloride 105.0 101.00 - 109.00 mmol/L
AVL 9180 Analyser
IMMUNOASSAY

Print DateTime: 20/04/2022 12:09 PM Printed By:Mohd Israr Ahmed Page 2 of 3

 NAME :Mrs. VIMLA GUPTA TEST REQUEST ID :012204200035
AGE/SEX :60 YRS/FEMALE REG DATE/TIME :20/Apr/2022 09:13AM
COLLECTED AT :LIFE SAMPLE COLLECTION DATE :20/Apr/2022 09:35AM
REFERRED BY :Dr. POONAM GUPTA, MD REPORTED DATE :20/Apr/2022 11:07AM

Test Name Result Ref. Range Unit

T3,T4,TSH
Triiodothyronine, Total (T3) 1.25 0.87-1.78 ng/ml
Chemiluminescence Micropartical Immunoassay
Thyroxine, Total (T4) 94.30 78.38-186.0 nmol/L
Chemiluminescence Micropartical Immunoassay
Thyroid Stimulating Hormone (TSH) 1.295 0.34 - 5.60 µIU/ml
Chemiluminescence Micropartical Immunoassay

Comment
T3 or 3 5 3 triiodothyronine is a hormone synthesized and secreted from the thyroid gland, and formed by peripheral deiodination of thyroxine (T4). The
determination of T3 levels in serum is essential in assessing thyroid functions. T3 is secreted by thyroid glands and circulates in the blood stream; mostly
(99.7%) bound to the plasma protein, thyroxin binding globulin (TBG) and prealbumin (TBPA) and albumin. The remaining (0.3%) is free, unbound and its
metabolic potency is much greater. T3 hormone regulates cell metabolism and body growth and its level is a good indicator of thyroid disease state and
body metabolism. Further the concentrations of the carrier protein are altered in many conditions such as pregnancy in normal thyroid function, as the
concentrations of the carrier proteins alters, the total T3 level changes so that free T3 concentration remains constant. Thus, measurements of the free T3
concentrations correlate excellently with clinical status than total T3 levels.
T4 or Thyroxine or 3,5,3,5-tetraiodothyronine is a hormone synthesized and secreted by the thyroid gland and plays an important role in regulating
metabolism. In the peripheral tissues it act as a prohormone which is further metabolized to another most active thyroid hormone, tri-iodothyronine (T3)
and other inactive metabolites such as reverse T3.
TSH or Thyroid-stimulating hormone is a hormone synthesized and secreted by Pituitary gland. TSH is glycoprotein with two non-covalently bound
alpha and beta subunits. The beta subunit of TSH is unique, which results in the specific biochemical and immunological properties of this hormone. The
ability to quantitate circulating levels of TSH is important in evaluating thyroid function. It is especially useful in the differential diagnosis of primary
(thyroid) from secondary (pituitary) and tertiary (hypothalamus) hypothyroidism. In primary hypothyroidism, TSH levels are significantly elevated, while
in secondary and tertiary hypothyroidism, TSH levels are low. The measurement of serum TSH has proven to be one of the most sensitive methods for
the detection of primary hypothyroidism. In primary hypothyroidism the production of thyroid hormones is impaired and the TSH levels are observed to
be higher. However in secondary and tertiary hypothyroidism the TSH levels are low because of pituitary of hypothalamic lesions. In hyperthyroidism the
circulating levels of TSH is usually subnormal. In some instance however this condition may result from hyperstimulation of thyroid.

Checked By:....... *** End Of Report ***

Print DateTime: 20/04/2022 12:09 PM Printed By:Mohd Israr Ahmed Page 3 of 3